Fundraising Fox

Imel BioTherapeutics

Waltham, US · Founded 2019 · 2 known investors

Healthtech

Founders & leadership

DP
Dori PelledExecutive

Board

TITaro Inaba
Taro InabainBoard directorManaging Partner at Remiges Ventures, Inc.
TK
Tomer KarivBoard directorChief Executive Officer at Pontifax Venture Capital
SN
Silvia Noiman, Ph.D.Board director

Investors · 2

Pontifax Venture CapitalHerzeliya · $6.3M – $128M
Remiges Ventures, Inc.Seattle

Reported raises · per SEC filings

Form D private placements

$15M disclosed across 1 round · 2021

▶$15MraisedNov 2021 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Taro InabaDirector
  • Tomer KarivDirector
  • Dori PelledExecutive Officer
  • Silvia Noiman, Ph.D.Executive Officer, Director
Offering amount
$20M
Amount sold
$15M
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Imel BioTherapeutics's investors?
Imel BioTherapeutics's investors include Pontifax Venture Capital, Remiges Ventures, Inc..
How much funding has Imel BioTherapeutics raised?
Imel BioTherapeutics has disclosed $15M raised across 1 round.
Where is Imel BioTherapeutics headquartered?
Imel BioTherapeutics is headquartered in Waltham, US.